Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001564590-17-000511
Filing Date
2017-01-23
Accepted
2017-01-23 17:01:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT, ITEM 5.02 mstx-8k_20170117.htm 425 57852
2 EX-10.1 mstx-ex101_28.htm EX-10.1 14502
  Complete submission text file 0001564590-17-000511.txt   74368
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Filed by) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Subject) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-32157 | Film No.: 17541568
SIC: 2834 Pharmaceutical Preparations